Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Higher versus standard maintenance dose SMART with Symbicort in moderate-severe persistent asthma
ChiCTR-TRC-14004770Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in asthma (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Lung function. Started Jun 2012; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-14004770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004770.